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Abstract
Exposure to ultraviolet radiation (UVR) is a major risk factor for both melanoma and non-
melanoma skin cancers. In addition to its mutagenic effect, UVR can also induce substantial
transcriptional instability in skin cells affecting thousands of genes, including many cancer
genes, suggesting that transcriptional instability may be another important etiological factor
in skin photocarcinogenesis. In this study, we performed detailed transcriptomic profiling
studies to characterize the kinetic changes in global gene expression in human keratino-
cytes exposed to different UVR conditions. We identified a subset of UV-responsive genes
as UV signature genes (UVSGs) based on 1) conserved UV-responsiveness of this subset
of genes among different keratinocyte lines; and 2) UV-induced persistent changes in their
mRNA levels long after exposure. Interestingly, 11 of the UVSGs were shown to be critical
to skin cancer cell proliferation and survival. Through computational Gene Set Enrichment
Analysis, we demonstrated that a significant portion of the UVSGs were dysregulated in
human skin squamous cell carcinomas, but not in other human malignancies. This high-
lights the potential and specificity of the UVSGs in clinical diagnosis of UV damage and
stratification of skin cancer risk.
Introduction
Skin cancer is the most common cancer in the US and has become a major public health prob-
lem due to rising incidence and treatment costs [1, 2]. Every year nearly 5 million cases of skin
cancers are treated, at an estimated cost of $8.1 billion [3]. There is compelling scientific and
epidemiological evidence that skin cancer is caused mainly by an interplay between genetic fac-
tors and exposure to solar UV radiation (UVR) [4–6]. Most skin cancer cases are preventable
through proper protection against excessive UV exposure. Sunscreen is one of the commonly
used sun protection strategies, especially in skin cancer susceptible populations [7]. However,
there are controversies surrounding the efficacy and safety of sunscreen products [8–11]. Cur-
rently, the sun-protection efficacy of sunscreens is measured by Minimal Erythema Dose
(MED), which refers to the lowest time interval or dosage of UV sufficient to produce a
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minimal, perceptible erythema on unprotected skin. As an indicator of UV damage, MED is
both insensitive and inadequate because significant molecular and cellular damage occurs at
sub-erythema UV doses that may contribute to cumulative photo damage [12, 13]. MED also
varies widely among different skin types. To reduce skin cancer incidence, sensitive biomarkers
and methods are needed for accurate assessment of UV-induced damage and evaluation of the
protective efficacy of sunscreen products to enhance skin cancer prevention.
Presently, no consensus panel of UV biomarkers is available for quantifying UV damage
and stratifying skin cancer risk. Previous studies have attempted to identify UV-responsive
genes as UV biomarkers [14–19]. However, there are significant variations in the experimental
designs including the choices of cell types, UV sources and doses, time points of analysis, and
expression profiling methods with different genomic coverage. Such variances make cross-
comparison and validation of previous findings challenging. To define a consensus UV bio-
marker panel with broad applicability and accuracy, we performed RNA-Seq studies to gener-
ate a transcriptomic cohort containing UV-responsive genes in human skin cells exposed to
different UVR conditions. We then performed rigorous bioinformatics analysis to define a UV
gene expression signature that is conserved among cells from different donors. We further
demonstrated that the UV signature genes (UVSGs) are significantly enriched in genes dysre-
gulated in human skin squamous cell carcinomas (SCCs), highlighting the potential clinical
utility of the UVSGs in risk prediction and stratification of skin cancer.
Material and Methods
Human keratinocyte cultures, human SCC and normal skin tissues
Primary human keratinocytes from neonatal foreskins were provided by the Columbia Univer-
sity Medical Center Skin Disease Research Center’s Tissue Culture and Histology Core facility.
The protocol was exempt by the Institutional Review Board at Columbia University. Keratino-
cytes from 4 individual donors (N0, N1, N2, and N6) were cultured in 154CF medium supple-
mented with human keratinocyte growth supplement (Life Technologies, Grand Island, NY).
Cells from each donor were maintained and analyzed separately. Human SCC tumor tissues
and adjacent normal skin tissues were obtained from the Molecular Pathology Shared
Resource/Tissue Bank of the Herbert Irving Comprehensive Cancer Center of Columbia Uni-
versity under CUMC IRB protocol AAAB2667.
UV radiation
Primary keratinocytes were propagated in culture for 2 to 3 passages in 10 cm culture dishes.
UVR was delivered using four FS20T12 UV tubes, which emit UV rays between 290 and 340
nm, with an emission peak at 310 nm [20]. Before UVR, cells were rinsed once with PBS and
irradiated in approximately 0.5 ml PBS in each 10 cm dish with 3 different doses: 10, 20, or 30
mJ/cm2, which was determined by an IL1400 radiometer connected to a SEL240/UVB-1/TD
detector [21]. Cells were collected at 4 h, 1 day or 3 days after UVR. The seeding density for
each UVR condition was adjusted based on a pre-determined LD50 UV dose (35 mJ/cm2 at 24
h after UVR) as follows [22]: 0.75x106/dish for control cells or cells irradiated with 10 mJ/cm2
UVR; 1x106/dish for cells irradiated with 20 mJ/cm2 UVR; 1.5x106/dish for cells irradiated
with 30 mJ/cm2 UVR (collected 1 day after UVR) or 3x106/dish for cells irradiated with 30 mJ/
cm2 UV (collected 3 days after UVR). Cells were allowed to recover for 24 h after subculture.
UVR was applied in the order of 3 days, 1 day, and 4 h prior to the collection of all cells on the
same day to ensure that all cells were cultured for the same amount of time within each
experiment.
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RNA isolation and RNA-Seq analysis
Total RNA was isolated from cultured keratinocytes, human SCC tissues, and adjacent normal
skin tissues using the RNeasy Kit (QIAGEN, Gaithersburg, MD). All RNA samples were subse-
quently analyzed using an RNA 6000 nano chip (Agilent Technologies, Wilmington, DE) to
confirm that the RNA integrity index was 8.0 or above. Total RNA (500 ng) from each sample
was subjected to poly-A pull-down to enrich mRNAs for library preparation by using Illumina
TruSeq RNA prep kit (Illumina, San Diego, CA). The resulting libraries were sequenced using
Illumina HiSeq2000 at Columbia Genome Center. Sequencing reads were mapped to the human
reference genome (NCBI/build37.2) using Tophat (version 2.0.4). Differentially expressed genes
(DEGs) between each UVR-treated group and the control group were determined using the
DESeq software package [23], which is an R Bioconductor package that defines DEGs based on
sequence read counts data. DESeq uses a negative binomial model to approximate the distribu-
tion of read counts and estimate the mean and variance of the dispersion. We selected DEGs
using fold change (FC) cutoffs set at>2 or<0.5 between irradiated and non-irradiated keratino-
cytes. A False Discovery rate (FDR) of<0.05 was used to control for false discoveries.
Bioinformatics and statistical analyses
DEG lists were used in principal component analysis (PCA) to test the variations in transcrip-
tomic response to different UVR conditions among the keratinocyte lines. PCA is a statistical
method that performs orthogonal linear transformation to convert a gene expression matrix
into a linearly uncorrelated variable called the principle component (PC) [24]. Each PC is a lin-
ear combination of the original gene expression values. The first two PCs contain the most var-
iance in the data, and could be visualized in 2-dimentional space. DAVID is a free online
bioinformatics resource for systematic analyses of gene function classification, annotation and
clustering based on various databases including KEGG, BioCarta, and Gene Ontology [25]. We
used DAVID to identify the biological pathways in which the UV-induced DEGs were
enriched. To determine the overlap between UVSGs and SCC signature genes, we performed
gene set enrichment analysis (GSEA), which computes the enrichment of a pre-defined gene
set on a gene signature generated by fold-change, t-test or other method using the Kolmogo-
rov-Smirnov statistic [26].
We used Paired t-test to identify genes displaying time-dependent UVR responses following
exposure. To identify genes manifesting UV dose-dependent changes, we constructed a linear
regression model using UV dose as an independent variable and gene expression as a dependent
variable for each gene in the same keratinocyte line and at the same time point. To evaluate the
overall effects of the various UVR doses on the expression of a specific gene, we integrated the
multiple p-values from every regression analysis for that gene using Fisher's Method.
To obtain cancer-specific gene signatures for various human malignancies, we retrieved the
RNA-Seq raw counts from The Cancer Genome Atlas (TCGA) database, which contains geno-
mic and clinical information for tumors and their matching normal tissues across over 30 can-
cer types from more than 11,000 patients (publically available at cancergenome.nih.gov). We
selected RNA-Seq data sets with both primary tumors and matched normal tissues for each
tumor type. We generated DEG sets for each tumor type using the DESeq software package. To
identify genes critical to skin cancer cell proliferation or survival, we queried the Achilles data-
base with 67 of the UVSGs that were upregulated by UVR [27]. Genes were considered essen-
tial to skin cancer cell survival if their corresponding shRNAs became depleted after 40 days or
16 population doublings following shRNA infection. Normalized shRNA depletion scores were
downloaded from the "cBOTv8_sbsv3_allreps_log.gct2” file in the Achilles database. All statis-
tical analyses were performed using the R software package.
Transcriptomic Signature Genes of UV Radiation
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Results
Transcriptomic responses to different UVR conditions
In addition to its mutagenic effect, UVR can cause genome-wide transcriptional instability
affecting thousands of genes [14–16]. To fully characterize UVR-induced transcriptomic
changes, we conducted RNA-Seq to profile mRNA expression changes in keratinocytes isolated
from 4 individual donor foreskins in response to different UVR doses at varied time points
after exposure. The resulting 22 DEG lists were subjected to principle component analysis
(PCA) to visualize the similarities of the DEG profiles in response to different UVR conditions.
As shown in Fig 1A, DEG profiles from Day 1 and 3 groups, but not the 4 h group, demon-
strated great similarities in the first principle component (PC1). Along the second principle
component (PC2) axis, the range of differences among the Day 3 DEG lists appeared smaller
than that of the Day 1 DEG group, demonstrating a time-dependent increase in the similarity
of UVR-induced transcriptomic changes among different keratinocyte lines and different UVR
doses.
To uncover the biological pathways that were most responsive to UVR, we calculated the
average of the FC of each DEG from Day 1 and Day 3 DEG lists (S1 Table). Using an FC cutoff
of 2, we obtained a total of 531 genes that were upregulated (FC>2) and 610 genes that were
down-regulated (FC<0.5) in response to different UVR conditions. We performed DAVID
analysis to identify top biological pathways in which the upregulated genes and down-regulated
genes were enriched. DAVID revealed multiple pathways that were significantly modulated by
UVR. The down-regulated genes were significantly enriched in the following top biological
pathways: cell cycle regulation (83 genes), chromosome structure (19 genes), DNA damage
response (DDR) (59 genes), and microtubule organization (23 genes); whereas the upregulated
genes were enriched in pathways such as apoptosis (33 genes), defense inflammatory response
(43 genes), ectoderm epithelium development (36 genes), cell adhesion (4 genes) and leukocyte
activation (9 genes) (Fig 1B).
Time-dependent transcriptomic changes in response to UVR
The PCA analysis in Fig 1A revealed time-dependent changes in the transcriptome following
UVR. To identify which genes exhibit time-dependent UVR responses, we performed paired t-
tests to compare the FCs of Day 3 DEGs with those of Day 1 DEGs for each keratinocyte cell
line (N0, N1 and N2) under the same UVR dose. We found that 164 out of the 531 upregulated
genes had higher expressions at Day 3 than at Day 1 (FDR-corrected p-value<0.05); while 239
out of the 610 down-regulated genes were more repressed at Day 3 than at Day 1 at the same
p-value threshold (S2 Table). Two examples of time-dependent upregulation include
ADAMTSL4, encoding a disintegrin and metalloproteinase; and CST6, encoding a cystatin
superfamily protein. Examples of time-dependent down-regulation include UHRF1, encoding
a member of a subfamily of RING-finger type E3 ubiquitin ligases; and TRIP13, which encodes
a protein that interacts with thyroid hormone receptors (Fig 2).
Dose-dependent transcriptomic changes in response to UVR
Next, we tested which genes displayed dose-dependent mRNA expression changes in response
to UVR. To do so, we fitted linear regression models for each of the differentially expressed
genes using UVR doses (10, 20 and 30 mJ/cm2) as independent variables and gene expression
as the dependent variable for each keratinocyte cell line (N0, N1, N2) at the same time point
(Day 1 or 3). For each gene, we constructed 6 models representing the following 6 conditions:
N0-1d, N0-3d, N1-1d, N1-3d, N2-1d and N2-3d. We then integrated the 6 coefficient p-values
Transcriptomic Signature Genes of UV Radiation
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Fig 1. A: PCA analysis demonstrating time-dependent clustering of UV-responsive transcriptomic profiles in human keratinocytes;
B: DAVID pathway analysis illustrating the enrichment of UV-induced DEGs into different biological pathways. The size of the pie
chart is proportional to the number of genes in each pathway.
doi:10.1371/journal.pone.0163054.g001
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PLOS ONE | DOI:10.1371/journal.pone.0163054 September 19, 2016 5 / 14
from the 6 models using Fisher’s method. We found that 285 out of the 531 upregulated genes
showed dose-dependent up-regulation with FDR-corrected p-value<0.05, and 452 out of the
610 down-regulated genes demonstrated significant dose-dependent decreases in gene expres-
sion at the same FDR threshold (S3 Table). Dose-dependent changes in 8 representative genes
with the lowest p-values from each group are illustrated in Fig 3.
Identification of conserved UVR transcriptomic signature genes
The time-dependent kinetic changes illustrated in Fig 2 suggested that UVR might exert persis-
tent effects on a subset of genes, which may serve as UV gene expression signature with a bio-
marker potential for assessing UVR-induced skin damages. To identify UV-induced DEGs
with biomarker potential, we performed bioinformatics and statistical analyses on DEGs
derived from 30 mJ/cm2 UVR exposure to isolate DEGs that were conserved among different
donors (N0, N1, N2, and N6). We identified 401 conserved UV signature DEGs, which we des-
ignated as the putative UV biomarker panel (S4 Table). To test protein-protein interactions
(PPIs) among the protein products of these UVSGs, we performed STRING (Search Tool for
the Retrieval of Interacting Genes/Proteins) network analysis using the Pajek software (version
3.1) [28] based on the known and predicted protein interactions available in the STRING data-
base (version 10) [29]. A STRING cutoff score of 0.7 was used to select PPIs with high confi-
dence. Altogether, we found 54 vertices (genes) and 106 edges (interactions) among the
UVSGs (Fig 4A). Clustering analysis using the VOS algorithm [30] to maximize modularity
within each cluster revealed 11 modules that were connected with each other except the histone
protein cluster (Fig 4A). Among the UVSGs, 13 of them showed more than 5 interacting
Fig 2. Graphs showing time-dependent changes in gene expression of UVR-target genes at Day 3
(yellow) and Day 1 (red). The x-axis represents the sample names. The y-axis shows the log2 fold change of
gene expression between irradiated and non-irradiated control cells. ADAMTSL4 and CST6 showed time-
dependent upregulation, while UHRF1 and TRIP13 displayed time-dependent down-regulation in response
to UVR.
doi:10.1371/journal.pone.0163054.g002
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Fig 3. Plots showing dose-dependent down-regulation (upper two panels) and upregulation (lower two
panels) of UVR-induced DEGs. Each point represents a sample at the corresponding UVR dose. X-axis
represents three different UVR doses; Y-axis represents the log2 fold change of gene expression between
irradiated and non-irradiated control cells. N0-1d, N0-3d, N1-1d, N1-3d, N2-1d, and N2-3d are delineated in red,
orange, yellow, green, blue and cyan, respectively.
doi:10.1371/journal.pone.0163054.g003
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neighbors (degree), also known as the hubs on the PPI network, including IL6 (19), PTGS2
(15), and IL1B (12), highlighting the potentially central roles of these genes in mediating UVR
responses.
Dysregulation of UVSGs in human SCCs
Compelling evidence suggests that UVR is the main etiological factor in SCC pathogenesis [4,
31]. To test whether UVSGs were dysregulated in human SCCs, we performed similar RNA-
Seq analyses to identify DEGs in human SCCs by comparing the transcriptome of the SCC
tumor tissue with that of the adjacent normal skin from the same patient. We then performed
GSEA to determine the enrichment of the UVSGs in the SCC DEGs, or vice versa. As shown in
Fig 4B and 4C, GSEA analyses revealed a significant mutual enrichment between the UVSG
and the SCC signature (p = 0.006 and 0.02, respectively). When we used an SCC signature dis-
covered by microarray-based analyses [32], we observed a significant enrichment between the
SCC signature and the UVSG as well (p = 5.19e-05 by Fisher exact test analysis), confirming
the molecular similarities between the UVSG and SCC signature.
To test whether the identified UVSG is specific for skin cancer, we performed additional
GSEA analyses to compare the UVSG with gene sets dysregulated in 14 other human cancer
types (obtained from the TCGA RNA-Seq database). Each cancer type contained at least 6 pairs
of primary tumors and adjacent normal tissues (Table 1). We generated DEG sets specific for
each cancer type using paired t-test. Each resulting cancer DEG set was then used in GSEA anal-
yses to assess the mutual enrichment between the UVSG and each cancer signature. As summa-
rized in Table 1, there was no significant enrichment between the UVSG and other cancer
signatures (p>0.05) except for thyroid cancer (p = 0.0222, Table 1). The similarity between the
UVSG and thyroid cancer signature might be related to the fact that ionizing radiation is a sig-
nificant risk factor for thyroid cancer [33], and that UVR and other radiations may share com-
mon target genes involved in pathways such as DNA damage and inflammation. A recent
prospective study also found a non-linear association between UVR and thyroid cancer [34].
Further studies are needed to determine whether UVRmay indeed increase thyroid cancer risk.
To test the stability of the UV gene expression signature following exposure, we performed
RNA-Seq on keratinocytes exposed to 30 mJ/cm2 of UV to generate a UV-induced DEG list at
Day 21 after exposure. Cross-comparison of the UVSG with the Day 21 DEG list revealed an
overlap of 144 genes (Fig 4D and S5 Table) (p<2.2e-16 per Fisher's exact test), suggesting that
a significant portion of the UVSGs maintained their initial UV responsiveness long after expo-
sure. Furthermore, cross-comparison of the UVSG derived in keratinocytes and the SCC signa-
ture (consisting of DEGs between the SCC and adjacent normal skin tissues) revealed that the
UVSGs were significantly enriched in the SCC signatures (p<2.2e-16 per Fisher's exact test)
(Fig 4E and 4F), underscoring the potential of the UVSGs as biomarkers for assessing UVR
damage and predicting skin cancer risk.
Role of UVSGs in skin cancer cell proliferation and viability
Project Achilles leverages both biological and computational analyses to identify genes that
affect cancer cell survival and/or proliferation using a genome-wide shRNA library screening
in over 200 cancer cell lines [27]. Based on the degree of depletion of a specific shRNA-treated
cancer cell population following infection, a depletion score is assigned to each shRNA. The
depletion score is therefore inversely correlated with the role of its target gene in cancer cell
survival, based on the assumption that loss of a key cancer survival gene (due to RNAi effect) is
detrimental to the infected cells [27]. Given that Achilles data were derived from loss-of-func-
tion analysis, we focused on 67 UVSGs that were upregulated in both SCCs and by UVR
Transcriptomic Signature Genes of UV Radiation
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(FC>2). We have validated 25 of the 67 genes in the Achilles database in multiple cancer cells
lines. We queried the Achilles database with these 25 genes to determine which are critical to
skin cancer cell proliferation and/or survival. Using the Wilcoxon test, we determined that 11
out of the 25 genes had significantly lower depletion scores in skin cancer cell lines compared
to other non-skin cancer lines (p<0.05, Table 2), indicating that this subset of UVSGs may
play key roles in skin carcinogenesis. The depletion scores of the shRNAs targeting these 11
genes in 5 skin cancer cell lines, together with the median depletion scores of the same shRNAs
in non-skin cancer lines, and the p-values fromWilcoxon tests are summarized in Table 2.
These analyses suggest that a subset of UVSGs may be targeted in future skin cancer prevention
and therapeutic development.
Fig 4. A: Protein-protein interaction network map illustrating hub genes as well as their interacting partners
among UVSGs. Each vertice represents a gene in the PPI map and each edge indicates an interaction
between the two genes. Genes belonging to different clusters are presented in different colors. The size of
each vertice refers to the number of other genes that it is connected with, which is proportional to their
degrees (number of interacting genes); B: GSEA of the genes dysregulated in human SCCs (red bars)
against the UV signature. UVSGs were sorted from the highest (left end of the bar) to the lowest (right end of
the bar) based on their FC. The normalized enrichment score (NES) and p value are indicated; C: GSEA of
the UVSG set (red bars) against the SCC signature set. SCC signature genes were sorted from the highest
(left end of the bar) to the lowest (right end of the bar) based on their FC; D: Venn diagram showing the
overlap between UVSGs and DEGs at 21 days after UVR; E & F: Venn diagrams showing the overlap
between UVSGs and DEGs from two SCC patients.
doi:10.1371/journal.pone.0163054.g004
Transcriptomic Signature Genes of UV Radiation
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Discussion
Despite decades of research, no consensus panel of molecular biomarkers is available for accu-
rate assessment of UVR damage and stratification of skin cancer risk. mRNA transcripts have
been successfully used as molecular biomarkers to enable early detection and diagnosis of dis-
ease and to track disease progression. To facilitate the development of a biomarker-based sensi-
tive method to assess UVR damage and stratify skin cancer risk, we employed RNA-Seq to
identify UV-induced gene expression signatures to establish a UV biomarker panel. Utilizing
bioinformatics and statistical analyses, we compiled a UV biomarker panel consisting of 401
genes that are consistently altered by UVR and conserved among keratinocytes from different
Table 1. Summary of the GSEA results between UVSGs and gene sets dysregulated in different human cancers derived from the TCGA database.
Cancer tissue
origin
# of matched tumor/
normal samples
NES of tumor gene set on UVR
signature genes






Bladder 19 -2.96 -1.93 -2.445 0.993
Breast 110 -3.11 -1.43 -2.27 0.988
Colon 41 -1.47 -0.762 -1.116 0.868
Head & Neck 40 -1.87 -1.46 -1.665 0.952
Kidney (renal) 72 1.64 1.47 1.555 0.06
Kidney
(papillary)
32 -0.999 -1.22 -1.1095 0.866
Liver 50 -3.19 -2.17 -2.68 0.996
Lung (adeno) 57 -2.54 -1.41 -1.975 0.976
lung (squamous) 50 -3.29 -1.96 -2.625 0.996
Prostate 52 -1.42 -1.44 -1.43 0.924
Rectal 8 -0.944 -1.08 -1.012 0.844
Stomach 29 -1.85 0.356 -0.747 0.772
Thyroid ** 59 2.17 1.85 2.01 0.0222
Uterine 23 -3.35 -1.1 -2.225 0.987
NES: normalized enrichment score;
** indicates p-value < 0.05
doi:10.1371/journal.pone.0163054.t001
Table 2. Summary of the UVSGs critical for skin cancer cell survival.
Genes Skin vs. other cancer lines DS of skin cancer cell lines DS of other cancer cell lines
Wilcoxon. Test (p-value) A2058 C32 COLO741 HS944T SKMEL5 Median
SLPI 0.00141 -1.4 -1.33 -1.07 -0.875 -1.68 -0.599
KLK7 0.00468 -0.311 -0.375 -0.962 -0.706 -0.93 0.0862
KRT13 0.00621 -0.439 -0.159 -1.18 0.0826 -0.877 0.54
NHLH2 0.00933 -0.882 -1.78 -0.864 -0.98 -1.63 -0.449
GPRC5A 0.0106 -1.53 -1.78 -2.63 -1.29 -1.63 -0.963
HIST1H2BK 0.0167 -1.3 -0.579 -1.02 -1.44 -0.65 -0.361
IGFBP3 0.017 0.277 -1.22 0.332 0.677 0.286 0.765
SPOCD1 0.022 -0.833 -1.45 -0.861 -0.639 -1.21 -0.342
IFI27 0.0273 -0.0243 -2.92 -1.26 -1.13 -2.22 -0.528
KLK11 0.0286 -1.14 -1.63 -0.566 -0.914 -1.07 -0.577
TNFSF4 0.0374 -1.35 -2.3 -1.87 -1.33 -1.3 -1.17
DS: Depletion Scores
doi:10.1371/journal.pone.0163054.t002
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donors. We further demonstrate that alterations in the mRNA expression of the UVSGs per-
sisted 21 days after exposure, illustrating the stability and reliability of the identified UV bio-
marker genes in future diagnostic applications. The persistent gene expression changes may be
due to UVR-induced epigenetic changes in DNA methylation and/or histone modifications at
target gene loci following UVR. The dose-dependent response among some of the UVSGs fur-
ther suggests that this novel UV biomarker panel may offer quantitative assessments of UVR
skin damage and thus help identify individuals at increased levels of risk for developing skin
cancer.
While some of the UVR target genes uncovered in this study have been reported in previous
studies [14–17], we have identified many new UVR target genes due to the near-complete cov-
erage of the transcriptome by RNA-Seq compared to the limits of previous microarray-based
analyses. Our experimental design also allows comprehensive characterizations of the UV-
responsive kinetics in the keratinocyte transcriptome (Figs 2 and 3). We would like to point
out, however, that we performed only one RNA-Seq for each cell line at each UVR dose or time
point. Furthermore, our findings are based on cultured cells, which do not involve the complex
interactions between keratinocytes and other cell types in vivo. Therefore, additional valida-
tions of the identified UVSGs are warranted in future studies. Among the DDR genes down-
regulated by UVR (Fig 1B), many of them encode DNA helicases, DNA-dependent ATPases,
and pyrophosphatases that participate in DNA replication and repair (S6 Table). DDR plays
pivotal roles not only in maintaining genome integrity and stability, but it also has a broad
impact on cell cycle regulation, chromatin dynamics, and apoptosis [35]. This may explain the
observations that these related pathways all appear as the top UV-responsive pathways (Fig
1B). Among the genes upregulated by UVR exposure in the inflammatory response pathway,
HDAC5 and HADC9 are two epigenetic regulators belonging to the class IIA family of histone
deacetylases that are known to regulate adaptive immunity [36], underscoring the importance
of epigenetic regulation of UVR-induced skin immune response.
The UV biomarker panel identified in this study consists of more genes (401) than other
biomarker panels currently used in clinical diagnosis of various diseases [37–39]. A large bio-
marker panel can offer better coverage and accuracy in assessing UV impact and skin cancer
risk. New molecular tests can be developed based on the UV biomarker genes to replace the
current MED-based method in testing the UV-protective efficacy of sunscreen products. The
significant similarity between the UV signature and SCC signature suggests that such bio-
marker-based tests may also enable clinical diagnosis and skin cancer risk prediction in suscep-
tible individuals following severe sunburns. Due to the steep decreases in the run times and
costs of next-generation sequencing technologies, profiling an individual’s transcriptome has
become a feasible clinical undertaking. We anticipate that the UV biomarker panel, together
with ever-improving RNA-Seq and bioinformatics tools, will greatly facilitate the development
of next-generation diagnostic tests to enhance skin cancer prevention and early detection to
reduce the incidence of this prevalent human malignancy.
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